Quantcast

Latest Pulmonary embolism Stories

2014-03-10 08:22:19

-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides

2014-03-03 23:27:21

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news.

2014-03-02 23:01:19

The Firm is investigating testosterone lawsuits on behalf of men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, and other cardiovascular problems due

2014-02-26 23:30:33

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news.

2014-02-26 23:02:53

The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other serious cardiovascular problems,

2014-02-24 23:03:47

Another NuvaRing Lawsuit Filed by Wright & Schulte Contends A Woman Developed A Potentially Fatal Pulmonary Embolism Due To Using NuvaRing. Columbus, OH

2014-02-19 23:30:28

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news.

2014-02-19 23:30:15

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news.

2014-02-19 23:02:44

The Firm is evaluating testosterone treatment lawsuits on behalf of individuals who allegedly suffered heart attacks, strokes, deep vein thrombosis, and pulmonary embolism due to their use of

2014-02-10 23:01:52

The Firm is investigating testosterone lawsuits on behalf of men who experienced serious heart side effects, including heart attacks, strokes, pulmonary embolism and deep vein thrombosis, allegedly


Word of the Day
orbity
  • A bereavement by loss of parents or children; the state of being orbate; orbation.
The word 'orbity' ultimately comes from a Latin word meaning 'bereaved'.